Canopy Growth Corp

NASDAQ:CGC USA Drug Manufacturers - Specialty & Generic
Market Cap
$404.31 Million
Market Cap Rank
#11337 Global
#5082 in USA
Share Price
$1.07
Change (1 day)
+4.90%
52-Week Range
$0.83 - $1.93
All Time High
$568.90
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more

Canopy Growth Corp (CGC) - Total Assets

Latest total assets as of December 2025: $1.11 Billion USD

Based on the latest financial reports, Canopy Growth Corp (CGC) holds total assets worth $1.11 Billion USD as of December 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Canopy Growth Corp - Total Assets Trend (2010–2025)

This chart illustrates how Canopy Growth Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Canopy Growth Corp - Asset Composition Analysis

Current Asset Composition (March 2025)

Canopy Growth Corp's total assets of $1.11 Billion consist of 32.1% current assets and 67.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 12.4%
Accounts Receivable $52.78 Million 5.8%
Inventory $96.37 Million 10.5%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $87.20 Million 9.5%
Goodwill $46.04 Million 5.0%

Asset Composition Trend (2010–2025)

This chart illustrates how Canopy Growth Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Canopy Growth Corp's current assets represent 32.1% of total assets in 2025, a decrease from 100.0% in 2010.
  • Cash Position: Cash and equivalents constituted 12.4% of total assets in 2025, up from 6.5% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2010.
  • Asset Diversification: The largest asset category is inventory at 10.5% of total assets.

Canopy Growth Corp Competitors by Total Assets

Key competitors of Canopy Growth Corp based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Canopy Growth Corp - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.03 - 0.29

Lower asset utilization - Canopy Growth Corp generates 0.29x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -134.37% - -2.44%

Negative ROA - Canopy Growth Corp is currently not profitable relative to its asset base.

Canopy Growth Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.34 3.52 9.98
Quick Ratio 4.26 2.58 8.68
Cash Ratio 0.00 0.00 0.00
Working Capital $426.37 Million $ 244.07 Million $ 2.55 Billion

Canopy Growth Corp - Advanced Valuation Insights

This section examines the relationship between Canopy Growth Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.72
Latest Market Cap to Assets Ratio 0.44
Asset Growth Rate (YoY) -29.4%
Total Assets $917.70 Million
Market Capitalization $404.06 Million USD

Valuation Analysis

Below Book Valuation: The market values Canopy Growth Corp's assets below their book value (0.44 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Canopy Growth Corp's assets decreased by 29.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Canopy Growth Corp (2010–2025)

The table below shows the annual total assets of Canopy Growth Corp from 2010 to 2025.

Year Total Assets Change
2025-03-31 $917.70 Million -29.43%
2024-03-31 $1.30 Billion -46.70%
2023-03-31 $2.44 Billion -56.47%
2022-03-31 $5.61 Billion -17.85%
2021-03-31 $6.82 Billion +41.62%
2020-03-31 $4.82 Billion -44.82%
2019-03-31 $8.73 Billion +507.72%
2018-03-31 $1.44 Billion +112.04%
2017-03-31 $677.61 Million +372.66%
2016-03-31 $143.36 Million +200.08%
2015-03-31 $47.77 Million +84.01%
2014-12-31 $25.96 Million +403.78%
2014-03-31 $5.15 Million +914.83%
2013-03-31 $507.81K -6.68%
2012-03-31 $544.13K -3.39%
2011-03-31 $563.21K -4.26%
2010-03-31 $588.30K --